fr   en

Tableaux synoptiques (en anglais)

Parcourir par date
Rechercher par mot clé
Date: 2010-02-04
Biotech partner: Ariana Pharma (France) Fovea Pharmaceuticals (France)
Type of agreement: * other
Compound: services (Phase II clinical data analysis using KEM® (Knowledge Extraction and Management) decision support platform )
Nature of the agreement: Ariana Pharma and Fovea Pharmaceuticals will collaborate to carry out systematic analysis of Fovea's Prednisporin® phase II clinical data, in order to optimize clinical design and maximize the probability of successful further development of this drug.
Under the terms of the collaboration, Ariana Pharma deploys its KEM®(Knowledge Extraction and Management) decision support platform to perform this analysis.
The current collaboration is based on the use of KEM Clinicals, a new version of this decision support platform.
Financial terms of the agreement: Financial details were not disclosed.

Go back to previous page